High ROIC Stocks
IRMD is currently part of our High ROIC Stocks screen, indicating it generates strong returns on invested capital.
IRADIMED CORP (IRMD) Stock Price & Overview
NASDAQ:IRMD • US46266A1097
Current stock price
89.18 USD
-3.75 (-4.04%)
At close:
89.18 USD
0 (0%)
After Hours:
The current stock price of IRMD is 89.18 USD. Today IRMD is down by -4.04%. In the past month the price decreased by -10.1%. In the past year, price increased by 67.25%.
IRMD Key Statistics
52-Week Range50.31 - 107.9
Current IRMD stock price positioned within its 52-week range.
1-Month Range89.18 - 103.27
Current IRMD stock price positioned within its 1-month range.
- Market Cap
- 1.14B
- P/E
- 46.45
- Fwd P/E
- 42.03
- EPS (TTM)
- 1.92
- Dividend Yield
- 0.77%
IRMD Stock Performance
Today
-4.04%
1 Week
-4.68%
1 Month
-10.10%
3 Months
-11.58%
Longer-term
6 Months +13.65%
1 Year +67.25%
2 Years +119.60%
3 Years +114.22%
5 Years +222.07%
10 Years +444.78%
IRMD Stock Chart
IRMD Stock Screens
IRMD currently appears in the following ChartMill screener lists.
IRMD Technical Analysis
ChartMill assigns a technical rating of 4 / 10 to IRMD. When comparing the yearly performance of all stocks, IRMD is one of the better performing stocks in the market, outperforming 82.62% of all stocks.
Chartmill TA Rating
Chartmill Setup Rating
IRMD Fundamental Analysis
ChartMill assigns a fundamental rating of 8 / 10 to IRMD. IRMD scores excellent points on both the profitability and health parts. This is a solid base for a good stock.
Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend
IRMD Earnings
On February 10, 2026 IRMD reported an EPS of 0.54 and a revenue of 22.69M. The company beat EPS expectations (10.29% surprise) and beat revenue expectations (3% surprise).
Next Earnings DateApr 24, 2026
Last Earnings DateFeb 10, 2026
PeriodQ4 / 2025
EPS Reported$0.54
Revenue Reported22.692M
EPS Surprise 10.29%
Revenue Surprise 3.00%
IRMD Forecast & Estimates
8 analysts have analysed IRMD and the average price target is 121.04 USD. This implies a price increase of 35.73% is expected in the next year compared to the current price of 89.18.
For the next year, analysts expect an EPS growth of 10.5% and a revenue growth 11.66% for IRMD
Analysts
Analysts82.5
Price Target121.04 (35.73%)
EPS Next Y10.5%
Revenue Next Year11.66%
IRMD Groups
Sector & Classification
IRMD Financial Highlights
Over the last trailing twelve months IRMD reported a non-GAAP Earnings per Share(EPS) of 1.92. The EPS increased by 16.36% compared to the year before.
Income Statements
Revenue(TTM)83.81M
Net Income(TTM)22.48M
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | 26.82% | ||
| ROA | 20.67% | ||
| ROE | 23.76% | ||
| Debt/Equity | 0 |
Chartmill High Growth Momentum
EPS Q2Q%22.73%
Sales Q2Q%17.03%
EPS 1Y (TTM)16.36%
Revenue 1Y (TTM)14.43%
IRMD Ownership
Ownership
Inst Owners58.92%
Shares12.78M
Float8.10M
Ins Owners36.61%
Short Float %6.17%
Short Ratio6.12
IRMD Competitors/Peers
The largest stocks on the US markets in the "Health Care Equipment" sub-industry
| Symbol | Company Name | Technical Rating | Fundamental Rating | FPE | Market Cap |
|---|---|---|---|---|---|
| ABT | ABBOTT LABORATORIES | 14.76 | 166.816B | ||
| ISRG | INTUITIVE SURGICAL INC | 44.16 | 165.367B | ||
| SYK | STRYKER CORP | 21.64 | 129.577B | ||
| BSX | BOSTON SCIENTIFIC CORP | 17.07 | 90.642B | ||
| EW | EDWARDS LIFESCIENCES CORP | 26.46 | 46.953B | ||
| IDXX | IDEXX LABORATORIES INC | 38.43 | 46.307B | ||
| BDX | BECTON DICKINSON AND CO | 11.48 | 45.171B | ||
| GEHC | GE HEALTHCARE TECHNOLOGY | 13.98 | 33.834B | ||
| RMD | RESMED INC | 18.02 | 32.944B | ||
| DXCM | DEXCOM INC | 24.61 | 24.87B | ||
| ZBH | ZIMMER BIOMET HOLDINGS INC | 10.93 | 18.482B | ||
| PODD | INSULET CORP | 29.66 | 13.912B | ||
| GMED | GLOBUS MEDICAL INC - A | 20.58 | 13.095B |
Related stock screener links
View all stocks in the Health Care Equipment Industry | View all stocks in the Health Care Sector | View all stocks on the Nasdaq Exchange | Find stocks with similar TA and Setup ratings on the USA exchanges | Find stocks with similar Fundamental rating on the USA exchanges | Find more growth stocks the USA exchanges | Find the competitors with the best technical ratings on the USA exchanges | Find the competitors with the best fundamentals on the USA exchanges | Find the competitors with the best valuation on the USA exchanges | Find the competitors with the best dividend on the USA exchanges | Find the competitors with the best analyst ratings on the USA exchanges
About IRMD
Company Profile
IRadimed Corp. engages in the development, manufacture, marketing, and distribution of Magnetic Resonance Imaging compatible medical devices. The company is headquartered in Orlando, Florida and currently employs 166 full-time employees. The company went IPO on 2014-07-16. Its MRidium 3860+ MRI Compatible IV infusion pump system provides a non-magnetic Intravenous (IV) infusion pump system that is specifically designed for safe use during MRI procedures. Its MRidium MRI compatible IV infusion pump system has been designed with a non-magnetic ultrasonic motor with non-ferrous parts and other special features to deliver anesthesia safely and predictably and other IV medications or fluids during various MRI procedures. Its IRadimed 3880 MRI Compatible patient vital signs monitoring system has been designed with non-magnetic components and other features to monitor a patient’s vital signs safely and accurately during various MRI procedures. The firm sells its products primarily to hospitals and acute care facilities. The IRADIMED 3880 system operates dependably in magnetic fields up to 30,000 gauss.
Company Info
IPO: 2014-07-16
IRADIMED CORP
12705 Ingenuity Drive
Orlando FLORIDA 32708 US
CEO: Roger Susi
Employees: 166
Phone: 18009279800
IRADIMED CORP / IRMD FAQ
Can you describe the business of IRADIMED CORP?
IRadimed Corp. engages in the development, manufacture, marketing, and distribution of Magnetic Resonance Imaging compatible medical devices. The company is headquartered in Orlando, Florida and currently employs 166 full-time employees. The company went IPO on 2014-07-16. Its MRidium 3860+ MRI Compatible IV infusion pump system provides a non-magnetic Intravenous (IV) infusion pump system that is specifically designed for safe use during MRI procedures. Its MRidium MRI compatible IV infusion pump system has been designed with a non-magnetic ultrasonic motor with non-ferrous parts and other special features to deliver anesthesia safely and predictably and other IV medications or fluids during various MRI procedures. Its IRadimed 3880 MRI Compatible patient vital signs monitoring system has been designed with non-magnetic components and other features to monitor a patient’s vital signs safely and accurately during various MRI procedures. The firm sells its products primarily to hospitals and acute care facilities. The IRADIMED 3880 system operates dependably in magnetic fields up to 30,000 gauss.
Can you provide the latest stock price for IRADIMED CORP?
The current stock price of IRMD is 89.18 USD. The price decreased by -4.04% in the last trading session.
Does IRMD stock pay dividends?
IRADIMED CORP (IRMD) has a dividend yield of 0.77%. The yearly dividend amount is currently 1.18.
How is the ChartMill rating for IRADIMED CORP?
IRMD has a ChartMill Technical rating of 4 out of 10 and a ChartMill Fundamental rating of 8 out of 10.
What is the GICS sector and industry of IRMD stock?
IRADIMED CORP (IRMD) operates in the Health Care sector and the Health Care Equipment & Supplies industry.
What is the Price/Earnings (PE) ratio of IRADIMED CORP (IRMD)?
The PE ratio for IRADIMED CORP (IRMD) is 46.45. This is based on the reported non-GAAP earnings per share of 1.92 and the current share price of 89.18 USD.
What is the employee count for IRMD stock?
IRADIMED CORP (IRMD) currently has 166 employees.